跳至主要内容
临床试验/NCT05992870
NCT05992870招募中不适用

Neoadjuvant Radiotherapy and Immediate Implant-Based Breast Reconstruction

Hubei Cancer Hospital1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2023年7月8日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
40
试验地点
1
主要终点
Postoperative complications at 3 months following skin-sparing mastectomy and immediate implant-based breast reconstruction after NART

研究概览

简要总结

Neoadjuvant radiotherapy(NART) followed by mastectomy and immediate DIEP flap reconstruction is feasible and technically safe. However, reports of NACT followed immediate implant-based breast reconstruction are rare. Some studies have shown that NART followed immediate implant-based breast reconstruction seems feasible and can be safely attempted. It's well known that radiotherapy after implant-based breast reconstruction have negative effects on implant and cosmetic results. So, investigators conducted a polit study to learn about acute post-surgical complications following skin-sparing mastectomy and immediate implant-based breast reconstruction after NART.

详细描述

Radiotherapy after implant-based breast reconstruction have negative effects on implant and cosmetic results, including severe capsular contracture, mastectomy flap necrosis ,reoperation and so on. Postmastectomy radiotherapy( PMRT )is associated with implant reconstruction failure. PRADA study has shown neoadjuvant radiotherapy followed by skin-sparing mastectomy and immediate DIEP flap reconstruction is feasible and technically safe. The investigators assume that neoadjuvant radiotherapy can avoid the negative effects of PMRT on an implant and the capsule of an implant and would lead to better cosmetic results and less complications compared to PMRT. Furthermore, some studies have shown that NART could potentially result in shorter time between diagnosis and treatment completion. So, investigators conducted a polit study to learn about acute post-surgical complications following skin-sparing mastectomy and immediate implant-based breast reconstruction after NART.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Women >18 years with histopathologically-confirmed breast cancer, who:
  • require mastectomy for any reason
  • a known indication for (adjuvant) radiotherapy
  • require implant-based breast reconstruction

排除标准

  • Inability to give informed consent
  • MDT unable to make recommendation for radiotherapy based on pre-operative histopathological and imaging findings
  • Previous history of breast cancer or another malignancy for which radiotherapy of the breast or axilla
  • Pregnant or lactating
  • inflammatory breast cancer

结局指标

主要结局

Postoperative complications at 3 months following skin-sparing mastectomy and immediate implant-based breast reconstruction after NART

时间窗: 3 months following skin-sparing mastectomy and immediate breast reconstruction

Surgical complications are defined as any complication requiring surgical intervention necessary within a period up to three months after the final reconstruction. Including Infection, hematoma , loss of implant or flap, fat necrosis, wound breakdown,defined and scored using the C-DC37.

次要结局

  • Patient satisfaction.(3 months and 12 months after surgery)
  • Number of participants with removal of implant.(6 months after surgery)
  • Number of participants with treatment-related adverse events as assessed by CTCAE v4.0 .(Within 3 months after both breast reconstruction and radiotherapy)
  • Pathological complete response (pCR) assessed in skin-sparing mastectomy specimen(Within 2 weeks after skin-sparing mastectomy)

研究者

发起方
Hubei Cancer Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Xinhong Wu, PhD

vice-president

Hubei Cancer Hospital

研究点 (1)

Loading locations...

相似试验